To ascertain whether interference with protein kinase CK2 activity or PRH expression would exacerbate endothelial dysfunction, HUVECs and HSaVECs were subjected to treatment with K66 or ectopic overexpression of PRH. This evidence concerns the gene WEE1 and endothelial dysfunction.